Mobergslien A - Search Results

1

Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins.

Sioud M, Mobergslien A, Boudabous A, Fløisand Y. Sioud M, et al. Among authors: mobergslien a. Int J Oncol. 2011 Feb;38(2):385-90. doi: 10.3892/ijo.2010.869. Epub 2010 Dec 9. Int J Oncol. 2011. PMID: 21165555

2

Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation.

Sioud M, Mobergslien A, Boudabous A, Fløisand Y. Sioud M, et al. Among authors: mobergslien a. Scand J Immunol. 2010 Apr;71(4):267-74. doi: 10.1111/j.1365-3083.2010.02378.x. Scand J Immunol. 2010. PMID: 20384870 Free article.

3

Optimized protocols for siRNA delivery into monocytes and dendritic cells.

Mobergslien A, Sioud M. Mobergslien A, et al. Methods Mol Biol. 2010;629:71-85. doi: 10.1007/978-1-60761-657-3_5. Methods Mol Biol. 2010. PMID: 20387143

4

Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production.

Mobergslien A, Sioud M. Mobergslien A, et al. J Leukoc Biol. 2012 Mar;91(3):461-7. doi: 10.1189/jlb.0711361. Epub 2011 Dec 13. J Leukoc Biol. 2012. PMID: 22167721

5

Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides.

Sioud M, Mobergslien A. Sioud M, et al. Among authors: mobergslien a. Bioconjug Chem. 2012 May 16;23(5):1040-9. doi: 10.1021/bc300050j. Epub 2012 Apr 10. Bioconjug Chem. 2012. PMID: 22443209

6

Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide.

Sioud M, Mobergslien A. Sioud M, et al. Among authors: mobergslien a. Biochem Pharmacol. 2012 Nov 1;84(9):1123-32. doi: 10.1016/j.bcp.2012.08.002. Epub 2012 Aug 14. Biochem Pharmacol. 2012. PMID: 22922046

7

Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients.

Sioud M, Saebøe-Larssen S, Hetland TE, Kaern J, Mobergslien A, Kvalheim G. Sioud M, et al. Among authors: mobergslien a. Int J Oncol. 2013 Jul;43(1):280-8. doi: 10.3892/ijo.2013.1922. Epub 2013 Apr 25. Int J Oncol. 2013. PMID: 23620105

8

A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells.

Sioud M, Skorstad G, Mobergslien A, Sæbøe-Larssen S. Sioud M, et al. Among authors: mobergslien a. FASEB J. 2013 Aug;27(8):3272-83. doi: 10.1096/fj.12-224758. Epub 2013 May 13. FASEB J. 2013. PMID: 23671272

9

Exosome-derived miRNAs and cellular miRNAs activate innate immunity.

Mobergslien A, Sioud M. Mobergslien A, et al. J Innate Immun. 2014;6(1):105-10. doi: 10.1159/000351460. Epub 2013 Jun 14. J Innate Immun. 2014. PMID: 23774807 Free PMC article.

10

Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses.

Sioud M, Mobergslien A, Sæbøe-Larssen S. Sioud M, et al. Among authors: mobergslien a. Methods Mol Biol. 2015;1218:269-76. doi: 10.1007/978-1-4939-1538-5_16. Methods Mol Biol. 2015. PMID: 25319657

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters